Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer

LESSONS LEARNED: Updated survival data for a phase I/II study of carboplatin plus nab‐paclitaxel and concurrent radiotherapy were collected. In the group of 58 patients who were enrolled at 14 institutions in Japan, the median overall survival was not reached and the 2‐year overall survival rate was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Tsuchiya‐Kawano, Yuko, Sasaki, Tomonari, Yamaguchi, Hiroyuki, Hirano, Katsuya, Horiike, Atsushi, Satouchi, Miyako, Hosokawa, Shinobu, Morinaga, Ryotaro, Komiya, Kazutoshi, Inoue, Koji, Fujita, Yuka, Toyozawa, Ryo, Kimura, Tomoki, Takahashi, Kosuke, Nishikawa, Kazuo, Kishimoto, Junji, Nakanishi, Yoichi, Okamoto, Isamu
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
Clinical Trial Results
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288639/
https://ncbi.nlm.nih.gov/pubmed/31649134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0746
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items